Results

Total Results: 1,172 records

Showing results for "cancer".
Users also searched for: colon cancer screening

81. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - • For single HSCT for high-risk Ewings sarcoma family of tumors, high-risk relapsed Wilm’s tumor, … and risk of second cancers in patients who have undergone stem cell transplant for cancer. … neoplasms. … LYSATE-PULSED DENDRITIC VACCINE FOR HIGH-RISK SOLID TUMORS A Pilot Study of Tumor Cell Vaccine … for High-risk Solid Tumor Patients Following Stem Cell Transplantation; University of Michigan Cancer

82. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
    January 01, 2024 - intended to inform primarily medical oncologists, alongside members of multidisciplinary teams and tumor … Recurrent cancer, metastatic cancer, early stage (T1aN0 and T1bN0), stage 4 cancer, GEJ cancer patients … stromal tumors (GIST), neuroendocrine tumors, gastric lymphoma, MALToma, other rare gastric cancers … To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … * OR carcinoma* OR malignan* OR neoplas* OR tumor* OR tumour*)):ab,ti,kw) 2 'cancer palliative therapy

83. Colorectal-Cancer-Screening Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
    February 01, 2012 - Adenoma—Benign tumor from epithelial tissue. … Stool DNA and occult blood testing for screen detection of colorectal neoplasia. … Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia … Detection of stool DNA mutations before and after treatment of colorectal neoplasia. … Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia

84. Gastric-Cancers-Supplementary-App-D (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
    January 01, 2023 - ROB 2 Study name Applicable outcome Randomization process Deviations from intended interventions Missing outcome data Measurement of the outcome Selection of the reported result Overall Comments ACTS-GC OS Low Low Low Low Low Low Low in all domains ACTS-GC Grade 3 to 5 AEs Low Low Low Low Low Low Low in all domains …

85. Data Points 14: Use of Endocrine Therapy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - For women with early invasive cancers, therapy was highest for women treated with BCS+RT and lowest … .1 Most breast cancers (about 75%) contain significant numbers of estrogen receptors (this is called … Use was lowest among women with ER- tumors. Use did not vary greatly across tumor size or grade. … For both groups, use was highest among women with ER+ tumors but was similar for women whose tumors … It appears that while rates of use are higher for women with early invasive cancers than for DCIS,

86. Cancer-Ovarian-Contraceptives Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - compared with other common cancers. … (KQ 1, KQ 2, and KQ 3); breast, cervical, colorectal, and endometrial cancers (KQ 4 and KQ 5); and … outcomes (KQ 1, KQ 2, KQ 3), 66 to other cancers of interest (KQ 4, KQ 5), and 50 to vascular events … Increase or decrease in age-specific incidence of cancers in ever OC users versus never users Figure … (decreased risk of ovarian, colorectal, and endometrial cancers) associated with OC use can affect

87. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
    January 01, 2023 - to draw conclusions regarding differences in IBR or other outcomes according to individual patient, tumor … is the leading cause of global cancer incidence and remains a leading cause of cancer mortality worldwide … , defined as a small tumor less than or equal to 3 cm that has minimal or no lymph node involvement … Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers … disease recurrences after breast conservation therapy based on location and histology: new primary tumors

88. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
    December 08, 2014 - cell lung cancer (SCLC) comprises approximately 15% of all lung cancers.2 The five-year survival rate … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … '/de OR cancer OR tumor* OR tumour* OR mass* OR neoplasm* AND (stage OR 'staging'/de OR staging OR class … OR tumor* OR tumour* OR mass* OR neoplasm*) AND (stage OR staging OR class*) Source: www.effectivehealthcare.ahrq.gov … [tiab] OR neoplasm[tiab] OR tumor*[tiab] OR tumour*[tiab]) AND (care[tiab] OR treatment[tiab] OR therapy

89. Data Points 16: Types of Prostate Radiation: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
    November 01, 2012 - outcomes, especially in higher risk tumors, although evidence is lacking.5 In 2000, Medicare began … that proportion had increased to 82 percent.9 Prior examinations of the same database have shown tumor … Higher doses of CRT are associ- ated with lower tumor recurrence rates. … tumors where the indications for IMRT are not very strong (i.e., where the risk of adjacent organ … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate

90. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
    July 01, 2012 - Background Prostate cancer is the fifth most common malignancy in the world,1 with a large variation … is indolent, and it is difficult to predict which tumors will be aggressive. … and no increase in the AUC of a model based on age, PSA, Gleason score, and tumor stage when SNPs … American Cancer Society. Cancer Facts & Figures 2010. … Two genome- wide association studies of aggressive prostate cancer implicate putative prostate tumor

91. Colorectal Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/colorectal-cancer

92. Head-Neck-Cancer-Update Espanol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_espanol.pdf
    April 01, 2016 - cerebral y el cáncer tiroideo no son tipos de cáncer de cabeza y cuello. 1 De acuerdo al National Cancer … información de este resumen proviene del informe actualizado Radiotherapy Treatments for Head and Neck Cancer … 2010 titulado Comparative Effectiveness and Safety of Radiation Therapy Treatments for Head and Neck Cancer … Atención Médica; AHRQ, por su sigla en inglés), visite www.effectivehealthcare.ahrq.gov/head-neck-cancer … Esta guía fue traducida de la publicación en inglés titulada Radiation Therapy for Head and Neck Cancer

93. Pancreatic Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/pancreatic-cancer

94. Executive Summary - Nutrition as Prevention for Improved Cancer Outcomes: Comparative Effectiveness Review No. 260 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
    May 01, 2023 - Studies were predominately conducted in individuals with gastrointestinal and head and neck cancers, … predominately examined dietary supplements and nutrition support in gastrointestinal and head and neck cancers … Studies were predominately conducted in populations with gastrointestinal and head and neck cancers, … glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors … versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy

95. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors … Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of … For example, among patients with solid tumors, the frequency of anemia severe enough to require red blood … cell transfusion is highest for those with lung, gynecologic, and genitourinary tumors. … Whether erythropoietic stimulants accelerate progression of some cancers, as reported by one study (n

96. Evidence-based Practice Center Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - The cancer is often localized, and most tumors have low histological grades and Gleason Scores. … half of them were expected to have early stage, low-risk tumors. 1 Thus, management of early stage … Tumor Characteristics i. Stage ii. Tumor volume iii. Gleason Score iv. PSA c. … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … Definition of Terms TNM = Tumor stage, node involvement, and metastasis. VII.

97. Lung Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/lung-cancer

98. Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/liver-cancer/research

99. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
    April 25, 2013 - The clinical trials in head-neck cancer patients were designed to improve outcomes by increasing tumor … trials and a Cochrane head-neck review) involving non-anemic patients with head-neck cancer, a malignancy … Page 23, line 27: This discussion focuses on hematologic malignancies. … Information on anemia prevalence in non-myeloid malignancies could be included here. … This has been revised to include non-myeloid malignancies.

100. Disposition of Comments for CER 167 Renal Masses (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
     February 24, 2016 - and malignant disease (many studies included only tumors confirmed to be cancer). … tumors in the cohort. … applicability to clinical decision making and the vast majority of patients presenting with renal cortical neoplasms … The main point is that larger tumors are associated with malignancy, and that the OR of 1.3 gives a … who proceeds to surgery as patient or tumor characteristics (i.e. male sex, larger tumors) influence